Clinical trial
Immunomodulating and neuroprotective properties of autologous multipotent mesenchymal stem cells in patients with multiple sclerosis - A randomised placebo-controlled double-blinded phase II study
To assess the effect of intra-venously applied autologous MSCs on cerebral inflammation in multiple sclerosis patients
| Category | Value |
|---|---|
| Study start date | 2012-06-21 |